Invention Grant
US09579352B2 Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC-37-01, MTCC 5856
有权
使用凝结芽孢杆菌SBC-37-01，MTCC 5856治疗腹泻主要肠易激综合征的治疗方法
- Patent Title: Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC-37-01, MTCC 5856
- Patent Title (中): 使用凝结芽孢杆菌SBC-37-01，MTCC 5856治疗腹泻主要肠易激综合征的治疗方法
-
Application No.: US14536701Application Date: 2014-11-10
-
Publication No.: US09579352B2Publication Date: 2017-02-28
- Inventor: Muhammed Majeed , Kalyanam Nagabhushanam , Natarajan Sankaran , Priti Vaidyanathan , Sivakumar Arumugam , Suresh Kumar Karri
- Applicant: Muhammed Majeed , Kalyanam Nagabhushanam , Natarajan Sankaran , Priti Vaidyanathan , Sivakumar Arumugam , Suresh Kumar Karri
- Applicant Address: IN Bangalore
- Assignee: SAMI LABS LIMITED
- Current Assignee: SAMI LABS LIMITED
- Current Assignee Address: IN Bangalore
- Main IPC: A01N63/00
- IPC: A01N63/00 ; A61K35/742 ; A61K35/00
Abstract:
The present invention discloses a process for the therapeutic management of diarrhea predominant irritable bowel syndrome in humans comprising the oral administration of Bacillus coagulans SBC37-01, MTCC 5856 (containing not less than 2 billion spores) along with standard treatment of care in a specific manner.
Public/Granted literature
Information query
